scholarly journals A Decade of Research on Coffee as an Anticarcinogenic Beverage

2021 ◽  
Vol 2021 ◽  
pp. 1-18
Author(s):  
Ayelén D. Nigra ◽  
Anderson J. Teodoro ◽  
Germán A. Gil
Keyword(s):  
Protective Factor ◽  
Coffee Consumption ◽  
In Vivo Studies ◽  
Inverse Association ◽  
Phytochemical Content ◽  
Coffee Drinking ◽  
Anticancer Properties ◽  
General Studies

Coffee consumption has been investigated as a protective factor against cancer. Coffee is a complex beverage that contains more than 1000 described phytochemicals, which are responsible for its pleasant taste, aroma, and health-promoting properties. Many of these compounds have a potential therapeutic effect due to their antioxidant, anti-inflammatory, antifibrotic, and anticancer properties. The roasting process affects the phytochemical content, and undesirable compounds may be formed. In recent years, there have been contradictory publications regarding the effect of coffee drinking and cancer. Therefore, this study is aimed at evaluating the association of coffee consumption with the development of cancer. In PubMed, until July 2021, the terms “Coffee and cancer” resulted in about 2150 publications, and almost 50% of them have been published in the last 10 years. In general, studies published in recent years have shown negative associations between coffee consumption and the risk or development of different types of cancer, including breast, prostate, oral, oral and pharyngeal, melanoma, skin and skin nonmelanoma, kidney, gastric, colorectal, endometrial, liver, leukemic and hepatocellular carcinoma, brain, and thyroid cancer, among others. In contrast, only a few publications demonstrated a double association between coffee consumption and bladder, pancreatic, and lung cancer. In this review, we summarize the in vitro and in vivo studies that accumulate epidemiological evidence showing a consistent inverse association between coffee consumption and cancer.

scholarly journals Health Beneficial Effects of Moomiaii in Traditional Medicine

2020 ◽  
Vol 9 ◽  
pp. 1743
Author(s):  
Solmaz Rahmani Barouji ◽  
Amir Saber ◽  
Mohammadali Torbati ◽  
Seyyed Mohammad Bagher Fazljou ◽  
Ahmad Yari Khosroushahi
Keyword(s):  
Traditional Medicine ◽  
English Language ◽  
Modern Medicine ◽  
In Vivo Studies ◽  
Beneficial Effects ◽  
Anticancer Properties ◽  
Language Studies ◽  
Health Complications

raditional medicine (TM) that developed over the years within various societies consists of medical experimental knowledge and practices, which apply natural methods and compounds for general wellness and healing. Moomiaii as a pale-brown to blackish-brown natural exudate is one of the natural compounds in traditional medicine that has been used over 3000 years in many countries of the world especially in India, China, Russia, Iran, Mongolia, Kazakhstan and Kirgizstan. We reviewed all English-language studies about Moomiaii that we accessed them. In traditional medicine, many beneficial activities have been attributed to Moomiaii and to its main constituents, Humic acid and Fulvic acid, which are widely used to prevent and treatment of different diseases. Some modern scientific investigations showed that Moomiaii as a safe dietary supplement can be beneficial in various health complications. Even though the beneficial effects of Moomiaii have been confirmed in traditional and modern medicine, it seems that additional in-vitro/in-vivo studies and comprehensive clinical trials are necessary to explain the whole mechanisms of action and to determine the effective doses in various diseases. We discuss and clarify the claimed health beneficial effects of Moomiaii in some wide-spread diseases regarding its anti-ulcerogenic, immunomodulatory, antidiabetic, antioxidative and anticancer properties. [GMJ.2020;9:e1743]

scholarly journals PHYTOPHARMACOLOGY OF HOLMSKIOLDIA SANGUINEA RETZ.: A REVIEW

2021 ◽  
Vol 12 (6) ◽  
pp. 52-59
Author(s):  
Rajeev Sati ◽  
Monika Bisht
Keyword(s):  
Asia Pacific ◽  
In Vivo Studies ◽  
Anticancer Properties ◽  
Anti Cancer ◽  
Central Nervous System Depressant ◽  
Botanical Description ◽  
Plant Constituents ◽  
Phytochemical Constituents

Holmskioldia sanguinea Retz. is a Sub-Himalayan plant that has been cultivated in the Americas, Europe, Indo-china, Asia-Pacific, and Southern Africa. It has been used traditionally to treat rheumatism and rheumatoid arthritis, dysentery, headaches, hypertension, boils, blain, ulcers, and gynaecological problems, as well as a blood purifying concoction. The botanical description of the plant, its phytochemical constituents, and its pharmacological activities are discussed, with an emphasis on antibacterial, antihepatotoxic, antifungal, anti-inflammatory, antioxidant, antimicrobial, analgesic, central nervous system depressant, diuretic, oestrogenic, anti-implantation, and anticancer properties. Most pharmacological effects are a result of plant constituents such as alkaloids, terpenoids, tannins, flavonoids, glycosides and phenols, to name a few. Conventional wisdom should be confirmed through in vitro and in vivo studies, as well as clinical trials. Herb's anti-tumor and anti-cancer properties have generated significant interest.

scholarly journals The STANDARDIZATION OF A TRADITIONAL POLYHERBAL FORMULATION WITH PHARMACOGNOSTIC STUDY; ITS PHYTOCHEMICAL CONTENT, ANTIOXIDANT, AND ANTIDIABETIC ACTIVITY

2019 ◽  
pp. 182-190
Author(s):  
ARUNIKA SUBBA ◽  
PALASH MANDAL ◽  
Arunika Subba
Keyword(s):  
Antioxidant Activity ◽  
Reducing Power ◽  
Acetone Extract ◽  
In Vivo Studies ◽  
Antidiabetic Activity ◽  
Scavenging Activity ◽  
Phytochemical Content ◽  
Soxhlet Apparatus

Objective: Pharmacognostic study, evaluation of antioxidant and antidiabetic activity along with phytochemical contents of an ethnomedicine (AR) which is used for the treatment of arthritis and diabetes in some villages of West Sikkim. Methods: The herbal formulation was extracted in a Soxhlet apparatus successively in ten solvents from low to high polarity. The extracts were subjected to antioxidant activity, qualitative and quantitative phytochemical estimation as well as in vitro antidiabetic activity. For pharmacognostic characterization, parameters such as fluorescence activity, physicochemical values, powder microscopy, and thin-layer chromatography (TLC) were performed. Mean values with p<0.05 were considered significant in statistical analysis. Results: Pharmacognostic study revealed various plants tissues. Ash values suggested the presence of earthy materials and moisture content near to the maximum range. Variation of colors was exhibited by AR in fluorescence analysis. TLC expressed the presence of phytoconstituents and the Rf values were noted down to be used in the future for authentication of the sample. Potential antioxidant capacity was observed in AR, phenolics significantly contributing in 1,1-diphenyl-2-picrylhydrazyl scavenging activity, 2, 2’-azinobis (3-ethylbenzothiazoline-6-sulfonic acid)+ scavenging activity and reducing power. Non-polar solvent showed the presence of alkaloid and steroids. The antidiabetic activity was very high in some extracts of AR with acetone extract showing the highest enzyme inhibiting activity. IC50 of acetone extract was 0.26±0.003 mg/ml. Conclusion: Overall study established a basic reference for the formulation AR. It was considered to possess antioxidant activity, but the interesting part of the study was its antidiabetic activity which is needed to be validated with in vivo studies and toxicity assessment.

scholarly journals Association between Polyphenol Intake and Gastric Cancer Risk by Anatomic and Histologic Subtypes: MCC-Spain

Nutrients ◽  
2020 ◽  
Vol 12 (11) ◽  
pp. 3281
Author(s):  
María Rubín-García ◽  
Facundo Vitelli-Storelli ◽  
Antonio José Molina ◽  
Raúl Zamora-Ros ◽  
Nuria Aragonés ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Total Phenolic ◽  
Inverse Association ◽  
Histological Subtypes ◽  
Anticancer Properties ◽  
Epidemiologic Evidence ◽  
Polyphenol Intake ◽  
The Relationship

Several anticancer properties have been largely attributed to phenolics in in vivo and in vitro studies, but epidemiologic evidence is still scarce. Furthermore, some classes have not been studied in relation to gastric cancer (GC). The aim of this study was to assess the relationship between the intake of phenolic acids, stilbenes, and other phenolics and the risk of developing GC and its anatomical and histological subtypes. We used data from a multi-case-control study (MCC-Spain) obtained from different regions of Spain. We included 2700 controls and 329 GC cases. Odds ratios (ORs) were calculated using mixed effects logistic regression considering quartiles of phenolic intake. Our results showed an inverse association between stilbene and lignan intake and GC risk (ORQ4 vs. Q1 = 0.47; 95% CI: 0.32–0.69 and ORQ4 vs. Q1 = 0.53; 95% CI: 0.36–0.77, respectively). We found no overall association between total phenolic acid and other polyphenol class intake and GC risk. However, hydroxybenzaldehydes (ORQ4 vs. Q1 = 0.41; 95% CI: 0.28–0.61), hydroxycoumarins (ORQ4 vs. Q1 = 0.49; 95% CI: 0.34–0.71), and tyrosols (ORQ4 vs. Q1 = 0.56; 95% CI: 0.39–0.80) were inversely associated with GC risk. No differences were found in the analysis by anatomical or histological subtypes. In conclusion, a diet high in stilbenes, lignans, hydroxybenzaldehydes, hydroxycoumarins, and tyrosols was associated with a lower GC risk. Further prospective studies are needed to confirm our results.

scholarly journals Pleiotropic Effects of Metformin on Cancer

2018 ◽  
Vol 19 (10) ◽  
pp. 2850 ◽  
Author(s):  
Hans-Juergen Schulten
Keyword(s):  
Scientific Evidence ◽  
Cellular Level ◽  
Pleiotropic Effects ◽  
In Vivo Studies ◽  
Clinical Cancer Research ◽  
Anticancer Properties ◽  
Galega Officinalis ◽  
Anticancer Effects

Metformin (MTF) is a natural compound derived from the legume Galega officinalis. It is the first line antidiabetic drug for type 2 diabetes (T2D) treatment. One of its main antidiabetic effects results from the reduction of hepatic glucose release. First scientific evidence for the anticancer effects of MTF was found in animal research, published in 2001, and some years later a retrospective observational study provided evidence that linked MTF to reduced cancer risk in T2D patients. Its pleiotropic anticancer effects were studied in numerous in vitro and in vivo studies at the molecular and cellular level. Although the majority of these studies demonstrated that MTF is associated with certain anticancer properties, clinical studies and trials provided a mixed view on its beneficial anticancer effects. This review emphasizes the pleiotropic effects of MTF and recent progress made in MTF applications in basic, preclinical, and clinical cancer research.

scholarly journals Resveratrol: A Double-Edged Sword in Health Benefits

Biomedicines ◽  
2018 ◽  
Vol 6 (3) ◽  
pp. 91 ◽  
Author(s):  
Bahare Salehi ◽  
Abhay Mishra ◽  
Manisha Nigam ◽  
Bilge Sener ◽  
Mehtap Kilic ◽  
...  
Keyword(s):  
Current Data ◽  
In Vivo Studies ◽  
Natural Food ◽  
Potential Candidate ◽  
Food Ingredient ◽  
Anticancer Properties ◽  
Trans Stilbene ◽  
Bacteria And Fungi

Resveratrol (3,5,4′-trihydroxy-trans-stilbene) belongs to polyphenols’ stilbenoids group, possessing two phenol rings linked to each other by an ethylene bridge. This natural polyphenol has been detected in more than 70 plant species, especially in grapes’ skin and seeds, and was found in discrete amounts in red wines and various human foods. It is a phytoalexin that acts against pathogens, including bacteria and fungi. As a natural food ingredient, numerous studies have demonstrated that resveratrol possesses a very high antioxidant potential. Resveratrol also exhibit antitumor activity, and is considered a potential candidate for prevention and treatment of several types of cancer. Indeed, resveratrol anticancer properties have been confirmed by many in vitro and in vivo studies, which shows that resveratrol is able to inhibit all carcinogenesis stages (e.g., initiation, promotion and progression). Even more, other bioactive effects, namely as anti-inflammatory, anticarcinogenic, cardioprotective, vasorelaxant, phytoestrogenic and neuroprotective have also been reported. Nonetheless, resveratrol application is still being a major challenge for pharmaceutical industry, due to its poor solubility and bioavailability, as well as adverse effects. In this sense, this review summarized current data on resveratrol pharmacological effects.

scholarly journals Genus Ophiorrhiza: A Review of Its Distribution, Traditional Uses, Phytochemistry, Biological Activities and Propagation

Molecules ◽  
2020 ◽  
Vol 25 (11) ◽  
pp. 2611 ◽  
Author(s):  
Muhammad Taher ◽  
Siti Syazwani Shaari ◽  
Deny Susanti ◽  
Dayar Arbain ◽  
Zainul Amiruddin Zakaria
Keyword(s):  
Biological Activities ◽  
Wide Distribution ◽  
In Vivo Studies ◽  
Active Compounds ◽  
Phytochemical Content ◽  
Traditional Uses ◽  
Anti Cancer ◽  
Anticancer Compound

Almost 50 species of Ophiorrhiza plants were reviewed in this work and the main objective is to critically analyse their distribution, phytochemical content, biological activity, and propagation. Moreover, the information would be useful in promoting the relevant uses of the plant, especially in the medicinal fields based on in vitro and in vivo studies. To this end, scientific sources, including theses, PubMed, Google Scholar, International Islamic University Malaysia IIUM EBSCO, PubChem, and Elsevier, were accessed for publications regarding the Ophiorrhiza genus in this review. Scientific literature regarding the Ophiorrhiza plants revealed their wide distribution across Asia and the neighbouring countries, whereby they were utilised as traditional medicine to treat various diseases. In particular, various active compounds, such as alkaloids, flavonoids, and terpenoids, were reported in the plant. Furthermore, the Ophiorrhiza species showed highly diverse biological activities, such as anti-cancer, antiviral, antimicrobial, and more. The genus propagation reported could produce a high quality and quantity of potent anticancer compound, namely camptothecin (CPT). Hence, it is believed that the relevant uses of natural compounds present in the plants can replace the existing crop of synthetic anticancer drugs associated with a multitude of unbearable side effects. Additionally, more future studies on the Ophiorrhiza species should be undertaken to establish the links between its traditional uses, active compounds, and pharmacological activities reported.

Genistein as a Potential Anticancer Agent Against Head and Neck Squamous Cell Carcinoma

2018 ◽  
Vol 18 (3) ◽  
pp. 174-181 ◽  
Author(s):  
Fatima Ardito ◽  
Giovanni Di Gioia ◽  
Mario Roberto Pellegrino ◽  
Lorenzo Lo Muzio
Keyword(s):  
Head And Neck ◽  
Squamous Cell ◽  
Therapeutic Potential ◽  
Heart Diseases ◽  
Cell Cancer ◽  
In Vivo Studies ◽  
Treatment Protocols ◽  
Anticancer Properties

The use of nutraceuticals as protection drugs against chronic diseases gained a vast success. Many studies found that nutraceuticals may reduce the tumorigenic actions of carcinogens, inhibiting the adhesion and proliferation of tumor cells. Genistein is a natural isoflavone preventing osteoporosis, menopause problems and heart diseases. It is also known in China and Japan for its anticancer properties. The available treatment protocols for Head and neck squamous cell cancer (HNSCC) have led to poor results and new therapies are necessary. In this paper, we will review anticancer therapeutic potential of genistein and in vitro and in vivo studies that suggest its potential role in the treatments of HNSCC.

The Impact of Polyphenolic in The Management of Breast Cancer: Mechanistic Aspects and Recent Patents

2021 ◽  
Vol 16 ◽  
Author(s):  
Heba A.S. El-Nashar ◽  
Shaza H. Aly ◽  
Amirhossein Ahmadi ◽  
Mohamed El-Shazly
Keyword(s):  
Breast Cancer ◽  
Therapeutic Potential ◽  
Treatment Strategies ◽  
Underlying Mechanism ◽  
In Vivo Studies ◽  
Molecular Characteristics ◽  
Anticancer Properties ◽  
The Impact

Background: Breast cancer is the most frequently diagnosed type of cancer in women (2.1 million) and stands as the fifth leading cause of death. Several treatment strategies are available such as surgical resection, radiation, hormonal therapy, and conventional chemotherapy that are associated with severe adverse effects on the patients. Objective: This review aims to summarize the different studies (in vitro, in vivo, and new patents) concerning the therapeutic potential of plant polyphenolics in the management of breast cancer published in the period from January 2016 to January 2021. Moreover, this review will focus on the underlying mechanism of action and molecular characteristics of these compounds. Methods: The data of this review were collected from different scientific databases such as PubMed, Science Direct, Google Scholarship, sci-finder, and Egyptian Knowledge bank (EKB). Results: During the last period (2016-2021), the in vitro studies investigated about 52 natural compounds of polyphenolic nature with promising anti-breast cancer, while fourteen compounds were reported via in vivo studies. Besides, there were about fifteen compounds registered as patent drugs. Different mechanisms of action and molecular targets were reported to provide a great clarified base and precise reflection for the anticancer properties of these compounds against breast cancer. Conclusion: Polyphenolics represent a plentiful sources of anticancer lead compounds that stand against the progression of breast cancer invasion and metastasis.

scholarly journals Phenolic Compounds – An Emerging Group of Natural Compounds against Leukaemia: in vitro, in vivo and Clinical Applications

2021 ◽  
Author(s):  
Lucienne Gatt ◽  
Pierre Schembri Wismayer
Keyword(s):  
Phenolic Compounds ◽  
Kinase Inhibitors ◽  
Survival Rates ◽  
Absolute Lymphocyte Count ◽  
In Vivo Studies ◽  
Beneficial Effects ◽  
Anticancer Properties ◽  
All Trans Retinoic Acid

Leukaemia is the most common cancer in children under 15 years of age as well as the most common blood cancer in people older than 55. The use of all trans retinoic acid (ATRA) in combination with arsenic trioxide (ATO) for acute promyelocytic leukaemia (APL) and tyrosine kinase inhibitors for chronic myeloid leukaemia (CML) respectively, have improved survival rates. However, new, natural therapies are constantly being sought after to overcome issues with resistance, side effects and specificity. As a result of their range of health benefits, including anticancer properties, phenolic compounds have been extensively studied over the past two decades. One on hand, in vitro and in vivo studies highlight both the inhibitory as well as differentiation inducing effects of phenolics on different leukaemia types. On the other hand, clinical trials to date have shown their beneficial effects (decrease in the absolute lymphocyte count and lymphadenopathy) in CLL (Chronic lymphoblastic leukaemia) patients. Promising therapeutic candidates for future use include epigallocatechin-3-gallate, coumarin, and gallic acid, with the latter ideally used in combination with the conventional drugs daunorubicin and cytarabine.

Sign in / Sign up

Export Citation Format

Share Document